Syra Health Delivers a Second Straight Profitable Quarter but Warns Its Survival Is at Risk

summarizeSummary

Syra Health posted Q2 2026 net income of $250,242 on revenue of $2.4 million, its second straight profitable quarter, but warned it may lack the cash to survive the next 12 months without raising additional capital.

check_boxKey Events · Earnings and Guidance · SYRA

• Second Consecutive Profitable Quarter

  Driven by population health and healthcare workforce services, Q2 2026 net income reached $250,242 on revenue of $2.4 million, up 23% year-over-year.

• Going Concern Warning

  Management expressed substantial doubt about the company's ability to continue as a going concern, citing insufficient cash to fund operations for the next 12 months without additional capital.

• Precarious Cash Position

  As of June 30, 2026, cash and equivalents totaled $2.1 million, against an accumulated deficit of $9.23 million and working capital of $2.55 million.

• Customer Concentration Risk

  Humana accounted for 37% of revenues and 40% of accounts receivable, while FSSA contributed 18% of revenues, heightening vulnerability to contract losses.

auto_awesomeAnalysis · SYRA · Trade & Services

A second consecutive profitable quarter brought net income of $250,242 on $2.4 million in revenue, a 23% year-over-year increase. Yet the celebration is overshadowed by a going concern warning: management harbors substantial doubt about the company's ability to continue without raising additional capital within the next 12 months. The cash balance stands at just $2.1 million, and heavy customer concentration—Humana alone represents 37% of revenue—magnifies the risk. On the horizon, contract extensions and a potential CMS ACCESS Model partnership could eventually provide a durable revenue stream, but these contingent opportunities do not resolve the immediate liquidity crisis.